PerfuseCell Cronus A/S: Financial statements 2019
CVR: 31606810
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 220,101 and a net result of DKK 172,271 compared with DKK 167,685 the year before. That is a decrease of 58.6% compared with the year before. The profit margin was 78.3%. Equity in the 2019 report amounted to DKK 662,862. The solvency ratio was 100%.
- Revenue
- DKK 220,101
- Gross Profit
- DKK 172,271
- Profit/Loss
- DKK 172,271
- Equity
- DKK 662,862
- Total Assets
- DKK 662,862
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 220 t. | 172 t. | 172 t. | 663 t. | - |
| 2018 | 532 t. | 272 t. | 168 t. | 491 t. | - |
| 2017 | 1.7 mio. | 310 t. | 309 t. | 323 t. | - |
| 2016 | 0 | 0 | 0 | 14 t. | - |
| 2015 | 0 | 0 | -180 | 14 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
PerfuseCell Cronus A/S has published its annual report for 2018. Revenue came to DKK 532,018, and the net result was DKK 167,685.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.